Catalyst Pharmaceuticals Inc (CPRX) — Capital Reinvestment Ratio
Catalyst Pharmaceuticals Inc (CPRX) has a Capital Reinvestment Ratio of 0.00x as of March 2026, meaning it reinvests 0% of its operating cash flow ($59.59 Million) in capital expenditures ($27.00K). Check CPRX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Catalyst Pharmaceuticals Inc Capital Reinvestment Ratio (2019–2025)
This chart tracks Catalyst Pharmaceuticals Inc's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see Catalyst Pharmaceuticals Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Catalyst Pharmaceuticals Inc (2019–2025)
Year-by-year Capital Reinvestment Ratio for Catalyst Pharmaceuticals Inc from 2019 to 2025. See Catalyst Pharmaceuticals Inc (CPRX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $208.67 Million | $58.00K | ▼ -88.0% |
| 2024 | 0.00x | $239.81 Million | $556.00K | ▼ -99.6% |
| 2023 | 0.57x | $143.60 Million | $81.74 Million | ▲ +227691.4% |
| 2022 | 0.00x | $116.05 Million | $29.00K | ▼ -98.5% |
| 2021 | 0.02x | $60.37 Million | $1.02 Million | ▲ +6584.4% |
| 2020 | 0.00x | $45.03 Million | $11.39K | ▼ -54.8% |
| 2019 | 0.00x | $34.61 Million | $19.37K | — |